Innoviva (INVA) Receivables - Net (2013 - 2026)
Innoviva (INVA) posted Receivables - Net of $34.0 million for Q1 2026, down 41.72% on a QoQ basis from $58.4 million in Q4 2025, and up 103.95% year-over-year from $16.7 million in Q1 2025.
Innoviva (INVA) Receivables - Net (2013 - 2026) Analysis & Trends
Innoviva's Receivables - Net history runs 7 years deep, the most recent figure standing at $34.0 million for Q1 2026.
- Quarterly Receivables - Net rose 103.95% year-over-year to $34.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.0 million (up 103.95% YoY) and the FY2025 annual result came in at $58.4 million, down 11.55% from the prior year.
- Receivables - Net was $34.0 million for Q1 2026 at Innoviva, down from $58.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $69.6 million in Q4 2023 and bottomed at $6.7 million in Q3 2022.
- A 5-year average of $41.6 million and a median of $54.7 million in 2022 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2023 — Receivables - Net surged 745.53% — and 2024, when it plunged 76.56%.
- Innoviva's Receivables - Net stood at $54.7 million in 2022, then rose by 27.34% to $69.6 million in 2023, then slipped by 5.24% to $66.0 million in 2024, then dropped by 11.55% to $58.4 million in 2025, then sank by 41.72% to $34.0 million in 2026.
- Business Quant data shows INVA's Receivables - Net at $34.0 million in Q1 2026, $58.4 million in Q4 2025, and $63.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.01 Mn |
| Mar 31, 2026 | 34.01 Mn |
| Dec 31, 2025 | 58.35 Mn |
| Dec 31, 2025 | 58.35 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Jun 30, 2025 | 20.93 Mn |
| Jun 30, 2025 | 20.93 Mn |
| Mar 31, 2025 | 16.67 Mn |
| Mar 31, 2025 | 16.67 Mn |
| Dec 31, 2024 | 65.97 Mn |
| Dec 31, 2024 | 65.97 Mn |
| Sep 30, 2024 | 60.51 Mn |
| Sep 30, 2024 | 60.51 Mn |
| Jun 30, 2024 | 26.78 Mn |
| Jun 30, 2024 | 26.78 Mn |
| Mar 31, 2024 | 14.14 Mn |
| Mar 31, 2024 | 14.14 Mn |
| Dec 31, 2023 | 69.62 Mn |
| Dec 31, 2023 | 69.62 Mn |